Celadon Pharmaceuticals Plc (AIM: CEL), announces that, following the signing of an introductory sales contract with a long-established American business,

London, 23 May 2024 – Celadon Pharmaceuticals Plc (AIM: CEL), a UK-based pharmaceutical company focused on the development, production and sale of breakthrough cannabis-based medicines, announces that, following the signing of an introductory sales contract with a long-established American business, it has successfully shipped two different medical cannabis products to the United States, representing the Company’s […]

Go to Source

Powered by WPeMatico